Takeda Pharmaceutical Company Limited
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema

Last updated:

Abstract:

Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.

Status:
Grant
Type:

Utility

Filling date:

21 Jan 2015

Issue date:

10 Aug 2021